In February 2016, Chris and I had the privilege of meeting Danielle James and her husband at a LUNGevity Hope Summit in the Dallas area. Danielle benefited from the drug crizotinib that Chris was in the clinical trial for when it was FDA approved for lung cancer. They shared the same rare gene mutation. She is such an inspiration with what she is doing with her life, I just had to share. This is Danielle’s story (shared with her permission):
